Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, October 26, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Global talent leader WilsonHCG acquires Personify to further expand its healthcare and life sciences talent solutions
Life Sciences Times
-
January 10, 2023
0
Venture Capital
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases
Life Sciences Times
-
January 9, 2023
0
Venture Capital
DLA Piper Advises Arlington Capital Partners and Everest Clinical Research in Its Acquisition of Brightech International
Life Sciences Times
-
January 9, 2023
0
Venture Capital
QIAGEN Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics With NGS Technologies
Life Sciences Times
-
January 9, 2023
0
Venture Capital
AVS Raises $20 Million in Series B Round to Advance Pulsatile Intravascular Lithotripsy (PIVL) Solutions
Life Sciences Times
-
January 5, 2023
0
Venture Capital
Perspectum Completes $36 Million First Close of Series C Funding Led by Oppenheimer Holdings
Life Sciences Times
-
January 5, 2023
0
Venture Capital
Cardiac Dimensions Raises $35 Million in Series D Financing
Life Sciences Times
-
January 5, 2023
0
Venture Capital
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
Life Sciences Times
-
January 5, 2023
0
Venture Capital
Braskem Acquires taulman3D Expanding its Portfolio of Materials for Additive Manufacturing Applications
Life Sciences Times
-
January 4, 2023
0
Venture Capital
Ganymed Robotics Raises Additional €15 M through Series B Extension Bringing Total Amount to €36 M
Life Sciences Times
-
January 4, 2023
0
Venture Capital
Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics
Life Sciences Times
-
January 4, 2023
0
Venture Capital
Belharra Therapeutics Debuts With $130 Million in Funding
Life Sciences Times
-
January 4, 2023
0
1
...
54
55
56
...
115
Page 55 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026